LyondellBasell Industries N.V.

Fundamentals5.0
Price Action4.0
News Sentiment6.0
AI Rating
5.0

Key Drivers

  • Margin recovery
  • High debt
  • Dividend risk

AI
AI Summary

5.0

LYB should be viewed as a restructuring-and-deleveraging test rather than a durable earnings recovery: Q2's supply-driven margin surge is unlikely to represent mid-cycle profitability, so investors should require proof that asset rationalization and cost cuts sustain free cash flow and reduce $14.2B of debt before treating the dividend yield as secure.

Restructuring
CyclicalRisk
Deleveraging‍

Price Chart

Loading chart...

Financial Metrics

-
Revenue (TTM)
-
Net Income (TTM)
-
EPS (Q)
-
MCAP

Deep Analysis

Research tool. Not personalized advice.

Fundamental Analysis

5.0

Key Financial Insights:

  • •Margin recovery
  • •High debt
  • •Dividend risk

LYB's quarterly profitability and cash flow rebounded sharply, but high leverage, declining liquidity, and an uncovered annual dividend keep the outlook risky.

Recovery
Leverage

Price Behavior

4.0
Research tool. Not personalized advice. Technical analysis is for informational purposes only.

Key Price Behavior Insights:

  • •Downtrend intact
  • •Support test
  • •Weak momentum

LYB fell 8.1% last month and remains cautiously bearish below its $64.42 average, with $61.93 support needing to hold before a rebound is viable.

Bearish
SupportWatch
Support Level: $61.93
Resistance Level: $64.25–$65.43

Broke below the prior $62.55–$62.75 trading floor

Sentiment & News

6.0

Key News Insights:

  • •Earnings Outperformance
  • •Margin Risk
  • •Balance Sheet

LyondellBasell's stronger earnings, cost cuts, and improved balance sheet support upside, but margin normalization and mixed institutional flows temper the outlook.

LYB
Chemicals

The news is cautiously positive for LYB, though sustained gains depend on margins holding up as supply conditions normalize